1. PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer. (7th June 2021) Authors: Rugo, Hope S; Loi, Sherene; Adams, Sylvia; Schmid, Peter; Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Diéras, Véronique; Winer, Eric P; Kockx, Mark M; Peeters, Dieter; Chui, Stephen Y; Lin, Jennifer C; Nguyen-Duc, Anh; Viale, Giuseppe; Molinero, Luciana; Emens, Leisha A Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 12(2021) Page Start: 1733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗